💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Acura Pharmaceuticals, Inc. (ACUR)
« Back to company indexACUR Chatter Timeline
Stock Ticker for ACUR
Most Active Tweeters for ACUR
| User | Tweets |
|---|---|
| @InsiderAlerts4U | 2 |
| @FlashAlert_me | 1 |
Recent Tweets for ACUR
 |
@InsiderAlerts4U $ACUR: New Insider Filing on ACURA PHARMACEUTICALS, INC's Director IMMANUEL THANGARAJ: https://t.co/zVNaH9ibrk January 13th 2022, 2:01am |
 |
@FlashAlert_me $ACUR [15s. delayed] filed SEC form 4: Director THANGARAJ IMMANUEL: Converted securities 66,666 of Common Stock at… https://t.co/e9wdZKJ4Kd January 12th 2022, 9:01pm |
|
@InsiderAlerts4U $ACUR: New Insider Filing on ACURA PHARMACEUTICALS, INC's Director BRUCE F WESSON: https://t.co/RpiueT796B January 12th 2022, 6:01am |
|
@FlashAlert_me $ACUR [15s. delayed] filed SEC form 4: Director WESSON BRUCE F: Converted securities 66,666 of Common Stock at pri… https://t.co/dAnJ1Qdt86 January 11th 2022, 9:01pm |
|
@InsiderAlerts4U $ACUR: New Insider Filing on ACURA PHARMACEUTICALS, INC's Director GEORGE K ROSS: https://t.co/CNMZyk80rF January 11th 2022, 3:01am |
|
@FlashAlert_me $ACUR [15s. delayed] filed SEC form 4: Director ROSS GEORGE K: Converted securities 66,666 of Common Stock at pric… https://t.co/A16C2pgBxV January 10th 2022, 9:01pm |
|
@InsiderAlerts4U $ACUR: New Insider Filing on ACURA PHARMACEUTICALS, INC's Director WILLIAM G SKELLY: https://t.co/7YKackE9XL January 6th 2022, 12:01am |
|
@FlashAlert_me $ACUR [15s. delayed] filed SEC form 4: Director SKELLY WILLIAM G: Converted securities 66,666 of Common Stock at p… https://t.co/pfbbn85bi3 January 5th 2022, 9:01pm |
 |
@TWANewsOfficial $ACUR Dir SKELLY Acquires 66,666 of ACURA PHARMACEUTICALS, INC (ACUR) January 5th 2022, 9:01pm |
|
@FlashAlert_me $ACUR [15s. delayed] filed form 8-K on January 04, 16:06:14 https://t.co/0zABDCecMD January 4th 2022, 9:01pm |
 |
@investor_feed $ACUR 8-K Acura Pharmaceuticals (4 Jan, 4:06pm) ? Entry into a Material Definitive Agreement; Financial Statem… https://t.co/Qqav240xv1 January 4th 2022, 9:01pm |
 |
@SwingTradeOTC Rose Above 50 DMA today: $ACUR $TMGI ... https://t.co/s1ULVsF7kz December 30th 2021, 7:12pm |
|
@investor_feed $ACUR 8-K Acura Pharmaceuticals (28 Dec, 4:10pm) ? Entry into a Material Definitive Agreement; Financial State… https://t.co/PHwsLwiMQj December 28th 2021, 9:12pm |
|
@FlashAlert_me $ACUR [15s. delayed] filed form 8-K on December 28, 16:10:42 https://t.co/hFnlznJW1d December 28th 2021, 9:12pm |
 |
@newsfilterio Acura Pharmaceuticals Announces Third Quarter 2021 Financial Results $ACUR https://t.co/3ShHd9fqjC November 16th 2021, 3:11am |
 |
@MarcJacksonLA $ACUR Acura Pharmaceuticals Announces Third Quarter 2021 Financial Results https://t.co/EtQN0o4oQ7 November 15th 2021, 10:11pm |
 |
@otc_watch_news $ACUR #OTCQB Acura Pharmaceuticals, Inc. (ACUR: OTCQB) | Acura Pharmaceuticals Announces Third Quarter 2021 Financi… https://t.co/d6fE7AeREv November 15th 2021, 9:11pm |
 |
@Beeken_health $ACUR - Acura Pharmaceuticals Announces Third Quarter 2021 Financial Results https://t.co/14kGvYFK3p https://t.co/UWgQzmEsqV November 15th 2021, 9:11pm |
|
@FlashAlert_me $ACUR [15s. delayed]: Issued Press Release on November 15, 16:15:00: Acura Pharmaceuticals Announces Third Quarter… https://t.co/5idopnPZti November 15th 2021, 9:11pm |
 |
@StockNewsBot2 $ACUR Acura Pharmaceuticals Announces Third Quarter 2021 Financial Results https://t.co/hCc7QXAmFy November 15th 2021, 9:11pm |
 |
@CSIMarket $ACUR #Stocks On November 15, $ACUR #AcuraPharmaceuticals, emblematic for the #MajorPharmaceuticalPreparations indu… https://t.co/AsKbXhoHDO November 13th 2021, 8:11am |
 |
@dogeattache $ACUR Acura is bringing back the Integra https://t.co/bI4iLfm4t8 November 12th 2021, 2:11am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2022. All rights reserved.
DrugPatentWatch Video Training
Decision-making for generic drug entry and branded drug lifecycle management
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
This course answers the following questions to help you adapt:
- ✓ When will key drug patents expire?
- ✓ How can I find, evaluate, and plan for generic market entry opportunities?
- ✓ How can I find proprietary out-of-court settlements and deal terms?